Daniel M. Lipinski, MSc, DPhil
Assistant Professor of Ophthalmology & Visual Sciences
Assistant Professor of Cell Biology, Neurobiology and Anatomy
Medical College of Wisconsin Eye Institute
925 N. 87th Street
Milwaukee, WI 53226-0509
Email Dr. Lipinski
Current Research Interests
My interest lies in the development of safe and effective gene therapy treatments to prevent vision loss in people who have inherited or vascular diseases affecting their eye. As a consequence, my primary focus is to prevent cone photoreceptor degeneration, as cones mediate daytime vision, color discrimination and depth perception, and so are vitally important in our everyday lives. To pursue this goal, my research group takes a multi-disciplinary and highly collaborative approach, incorporating aspects of molecular and cell biology, virology, neuroscience, organic chemistry, imaging and more.
BSc, Biology, Imperial College London, UK
MSc, Virology, Imperial College London, UK
DPhil, Ophthalmology, University of Oxford, UK
Brief Biographical Information
I was born and went to school in the Southeast of England, where I was encouraged to pursue an interest in science. After growing up (somewhat) and finishing school, I attended Imperial College London, where I white-knuckled my way to honours degrees in Biology (BSc) and Virology (MSc) and developed a passion for the structure of viruses and how they can be used as gene transfer vectors. After graduating, I moved to the University of Oxford (or potentially, to Hogwarts), where I carried out my doctoral research (DPhil) under the supervision of Professor Robert E. MacLaren, a world-renowned clinician-scientist and expert in retinal gene therapy. In 2013, I moved to the University of Florida to work under the guidance of Professor William W. Hauswirth, a pioneer in the use of adeno-associated virus (AAV) vectors for gene therapy. Along the way, I established an independently funded research program and picked up several accolades, including a Young Investigator of the Year Award (Asia-ARVO, 2011), The Master’s Prize (Worshipful Company of Spectacle Makers, 2012) and the inaugural Fulbright-Fight for Sight Research Scholarship (2013). I was recently recognized as an Emerging Vision Scientist by the National Alliance for Eye and Vision Research (2016) and joined the faculty at Medical College of Wisconsin as an Assistant Professor, founding the Ocular Gene Therapy Laboratory (OGTL).